Research ArticleOriginal Article
Open Access

Impact of cyclooxygenase-2 over-expression on the prognosis of colorectal cancer patients

An experience from Western Saudi Arabia

Abdulkader M. Albasri, Mohammed A. Elkablawy, Akbar S. Hussainy, Hala M. Yousif and Ahmed S. Alhujaily
Saudi Medical Journal August 2018, 39 (8) 773-780; DOI: https://doi.org/10.15537/smj.2018.8.22837

References

  1. ↵
    1. Ferlay J,
    2. Soerjomataram I,
    3. Dikshit R,
    4. Eser S,
    5. Mathers C,
    6. Rebelo M,
    7. et al.
    (2013) Globocan 2012 v1.0, Cancer Incidence and Mortality Worldwide:IARC Cancer Base No. 11 [Internet] (International Agency for Research on Cancer, Lyon (FR)). [2015 November 2015].
  2. ↵
    1. International Association of Cancer Registries
    (2017) Saudi Cancer Incidence Report 2014. Saudi Cancer Registry (King Faisal Specialist Hospital & Research Center Council of Health Services, Riyadh (KSA)).
  3. ↵
    1. Ibrahim EM,
    2. Zeeneldin AA,
    3. El-Khodary TR,
    4. Al-Gahmi AM,
    5. Bin Sadiq BM
    (2008) Past, Present and Future of Colorectal Cancer in the Kingdom of Saudi Arabia. Saudi J Gastroenterol 14:178–182.
    OpenUrl
  4. ↵
    1. Albasri A,
    2. Yosef H,
    3. Hussainy AS,
    4. Sultan SA,
    5. Alhujaily AS
    (2014) Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia:8 years experience. Asian Pac J Cancer Prev 15:3133–3137.
    OpenUrl
  5. ↵
    1. Sobolewski C,
    2. Cerella C,
    3. Dicato M,
    4. Ghibelli L,
    5. Diederich M
    (2010) Role of Cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol 2010:215158.
    OpenUrlPubMed
  6. ↵
    1. Lin PC,
    2. Lin YJ,
    3. Lee CT,
    4. Liu HS,
    5. Lee JC
    (2013) Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patients. Oncol Lett 6:733–739.
    OpenUrl
  7. ↵
    1. Kazem A,
    2. El Sayed K,
    3. El Kerm Y
    (2014) Prognostic significance of COX-2 and b-catenin in colorectal carcinoma. Alexandria Journal of Medicine 50:211–220.
    OpenUrl
  8. ↵
    1. Al-Maghrabi J,
    2. Buhmeida A,
    3. Emam E,
    4. Syrjänen K,
    5. Sibiany A,
    6. Al-Qahtani M,
    7. et al.
    (2012) Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol 18:1793–9.
    OpenUrlPubMed
  9. ↵
    1. Peng L,
    2. Zhou Y,
    3. Wang Y,
    4. Mou H,
    5. Zhao Q
    (2013) Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer:a meta-analysis of the literature. PLoS One 8:e58891.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Elkablawy MA,
    2. Albasri AM
    (2015) High quality tissue miniarray technique using a conventional TV/radio telescopic antenna. Asian Pac J Cancer Prev 16:1129–1133.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Denkert C,
    2. Winzer KJ,
    3. Hauptmann S
    (2004) Prognostic impact of cyclooxygenase-2 in breast cancer. Clin Breast Cancer 4:428–433.
    OpenUrlPubMed
  12. ↵
    1. Mascaux C,
    2. Martin B,
    3. Paesmans M,
    4. Berghmans T,
    5. Dusart M,
    6. Haller A,
    7. et al.
    (2006) Has COX-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results. Br J Cancer 95:139–145.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Li L,
    2. Zhao J,
    3. Wu Z,
    4. Wang G,
    5. Chen G
    (2009) Meta-analysis:clinicopathological and prognostic significance of cyclooxygenase-2 expression on oesophageal squamous cell carcinoma. Aliment Pharmacol Ther 30:589–596.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Lin DT,
    2. Subbaramaiah K,
    3. Shah JP,
    4. Dannenberg AJ,
    5. Boyle JO
    (2002) Cyclooxygenase-2:a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792–799.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    1. Hammam OA,
    2. Aziz AA,
    3. Roshdy MS,
    4. Abdil Hadi A
    (2008) Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal associated bladder cancer. Medscape J Med 10:60.
    OpenUrlPubMed
  16. ↵
    1. Bayomi EA,
    2. Barakat AB,
    3. El-Bassuoni MA,
    4. Talaat RM,
    5. El-Deftar MM,
    6. Abdel Wahab SA,
    7. et al.
    (2015) Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma. J Cancer Res Ther 11:786–792.
    OpenUrl
  17. ↵
    1. Brown JR,
    2. DuBois RN
    (2005) COX-2:a molecular target for colorectal cancer prevention. J Clin Oncol 23:2840–2855.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Cooper K,
    2. Squires H,
    3. Carroll C,
    4. Papaioannou D,
    5. Booth A,
    6. Logan RF,
    7. et al.
    (2010) Chemo prevention of colorectal cancer:systematic review and economic evaluation. Health Technol Assess 14:1–206.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Arber N,
    2. Eagle CJ,
    3. Spicak J,
    4. Rácz I,
    5. Dite P,
    6. Hajer J,
    7. et al.
    (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355:885–895.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Charalambous MP,
    2. Lightfoot T,
    3. Speirs V,
    4. Horgan K,
    5. Gooderham NJ
    (2009) Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer 101:106–115.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Sano H,
    2. Kawahito Y,
    3. Wilder RL,
    4. Hashiramoto A,
    5. Mukai S,
    6. Asai K,
    7. et al.
    (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785–3789.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Chan AT
    (2010) COX-2 expression in adenoma:an imperfect marker for chemoprevention. Gut 59:568–569.
    OpenUrlFREE Full Text
  23. ↵
    1. Wasilewicz MP,
    2. Kołodziej B,
    3. Bojułko T,
    4. Kaczmarczyk M,
    5. Sulzyc-Bielicka V,
    6. Bielicki D
    (2010) Expression of cyclooxygenase-2 in colonic polyps. Pol Arch Med Wewn 120:313–320.
    OpenUrlPubMed
  24. ↵
    1. Nogueira RB,
    2. Pires AR,
    3. Soares TM,
    4. Rodrigues SR,
    5. Campos MA,
    6. Toloi GC,
    7. et al.
    (2013) Immunoexpression of the COX-2, p53, and caspase-3 proteins in colorectal adenoma and non-neoplastic mucosa. Einstein 11:456–461.
    OpenUrlPubMed
  25. ↵
    1. Benamouzig R,
    2. Uzzan B,
    3. Martin A
    (2010) Cyclooxygenase-2 expression and recurrence of colorectal adenomas:effect of aspirin chemo prevention. Gut 59:622–629.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Kawasaki T,
    2. Nosho K,
    3. Ohnishi M
    (2008) Cyclooxygenase-2 over-expression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma. BMC Cancer 8:33.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Dimberg J,
    2. Samuelsson A,
    3. Hugander A
    (1999) Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 45:730–732.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Dixon DA,
    2. Blanco FF,
    3. Bruno A
    (2013) Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia. Recent Results In Cancer Research 191:7–37.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Wu QB,
    2. Sun GP
    (2015) Expression of COX-2 and HER-2 in colorectal cancer and their correlation. World J Gastroenterol 21:6206–6214.
    OpenUrl
  30. ↵
    1. Jafarian AH,
    2. Kermani AT,
    3. Esmaeili J
    (2016) The role of COX-2 and Ki-67 over-expression in the prediction of pathologic response of rectal cancer to neoadjuvant chemoradiation therapy. Indian J Cancer 53:548–551.
    OpenUrl
    1. Güler SA,
    2. Uğurlu MU,
    3. Kaya H,
    4. Şen S,
    5. Nazlı YM,
    6. Güllüoğlu BM
    (2016) Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients. Güllüoğlu Ulus Cerrahi Derg 32:81–88.
    OpenUrl
  32. ↵
    1. Joo Y,
    2. Chung I,
    3. Park Y,
    4. Koh YS,
    5. Lee JH,
    6. Park CH,
    7. et al.
    (2006) Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer. J Korean Med Sci 21:871–876.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section